| ASSET | YEAR | % RETURN |
|---|---|---|
Erasca (ERAS) | 2026 | 322.1% |
CareDx (CDNA) | 2026 | 313.38% |
Kodiak Sciences (KOD) | 2026 | 298.39% |
Veradermics (MANE) | 2026 | 281.35% |
Pulse Biosciences (PLSE) | 2026 | 264.71% |
10X Genomics (TXG) | 2026 | 256.77% |
Twist Bioscience (TWST) | 2026 | 251.72% |
Oruka Therapeutics (ORKA) | 2026 | 247.58% |
TOP Financial (TOP) | 2026 | 236.63% |
Abcellera Biologics (ABCL) | 2026 | 235.96% |
Spyre Therapeutics (SYRE) | 2026 | 217.46% |
Okeanis Eco Tankers (ECO) | 2026 | 215.47% |
Enliven Therapeutics (ELVN) | 2026 | 214.84% |
MaxLinear (MXL) | 2026 | 212.84% |
Immunitybio (IBRX) | 2026 | 198.02% |
Tango Therapeutics (TNGX) | 2026 | 188.14% |
Iovance Biotherapeutics (IOVA) | 2026 | 179.14% |
PBF Energy (PBF) | 2026 | 166.88% |
Iridium Communications (IRDM) | 2026 | 165.1% |
Acadia Healthcare (ACHC) | 2026 | 164.2% |
Ringcentral (RNG) | 2026 | 161.89% |
Amylyx Pharmaceuticals (AMLX) | 2026 | 152.42% |
International Seaways (INSW) | 2026 | 150.29% |
Hinge Health (HNGE) | 2026 | 148.47% |
Hyperliquid Strategies Inc Common Stock (PURR) | 2026 | 146.46% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
